When will all UK be vaccinated with first shot? Some rough estimates to help think about the challenges.
1. Middle case
Just Moderna, Oxford, Pfizer vaccines approved, with smooth delivery:
a) Vulnerable 20m (40m doses) by early April
1. Middle case
Just Moderna, Oxford, Pfizer vaccines approved, with smooth delivery:
a) Vulnerable 20m (40m doses) by early April
b) Whole adult population covered around late August.
For all estimates add one month for second shot and immune response.
For all estimates add one month for second shot and immune response.
Best case: One more vaccine (say Novavax) gets approved with 60m doses. Again all smoothly delivered.
a) Vulnerable by late March - not much change because this has mainly happened by the time Novavax arrives.
b) Whole adult population by early July - maybe 6 weeks earlier.
a) Vulnerable by late March - not much change because this has mainly happened by the time Novavax arrives.
b) Whole adult population by early July - maybe 6 weeks earlier.
Worst case: No more vaccines approved, spotty delivery - so they come through a bit slower.
a) Vulnerable by early June.
b) Whole adult population by end of 2021, early 2022.
a) Vulnerable by early June.
b) Whole adult population by end of 2021, early 2022.
Two things stand out:
1. Pfizer & Oxford important because they combine being available now AND in large quantities.
2. Manufacturing delays are going to be really important - because they will slow vaccinating the vulnerable.
1. Pfizer & Oxford important because they combine being available now AND in large quantities.
2. Manufacturing delays are going to be really important - because they will slow vaccinating the vulnerable.
Approximate figures here: https://docs.google.com/spreadsheets/d/1C-NaExZCz2k_AD7pbY1g6ob-Q8U3S3m63d3edYaQ-Og/edit?usp=sharing
Worth noting that this gets wildly less useful beyond Spring 2021, because there are lots of vaccines in development.
As/when/if more get approved the non-vulnerable vaccination accelerates, and supply constraints likely fall a bit... https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?cmpid=BBD120620_CORONAVIRUS&utm_medium=email&utm_source=newsletter&utm_term=201206&utm_campaign=coronavirus
As/when/if more get approved the non-vulnerable vaccination accelerates, and supply constraints likely fall a bit... https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?cmpid=BBD120620_CORONAVIRUS&utm_medium=email&utm_source=newsletter&utm_term=201206&utm_campaign=coronavirus
... because different vaccines will have different supply constraints.
Obviously the global picture is much more complicated because the volume needed is roughly 100 times higher.
Obviously the global picture is much more complicated because the volume needed is roughly 100 times higher.